<?xml version="1.0" encoding="UTF-8"?>
<p>The existence of ADE in SARS‐CoV‐2 might aggravate the COVID‐19 pandemic with higher morbidity and mortality, when convalescent patients will encounter infections in the future by possibly mutated strains (
 <xref rid="cytoa24047-bib-0044" ref-type="ref">44</xref>, 
 <xref rid="cytoa24047-bib-0045" ref-type="ref">45</xref>). However, the evidence for distinct types or strains in the present stage of evolution of SARS‐CoV‐2, which could account for differences in morbidity and RBD binding affinity, is conflicting (
 <xref rid="cytoa24047-bib-0048" ref-type="ref">48</xref>).
</p>
